Sharon Brownlow, PhD, Cell and Gene Therapy Catapult, London, UK, talks on the importance of collaborating between different stakeholders across academia, healthcare and industry in order to overcome barriers in the cell and gene therapy (CGT) space. Dr Brownlow comments on a consortium created by Cell and Gene Therapy Catapult to help maintain confidentiality, and supporting companies in their manufacturing process. Dr Brownlow additionally highlights the benefits of harnessing the power of pre-competitive collaboration. This interview took place at Advanced Therapies Week 2022.
Sharon Brownlow, PhD, is an employee of Cell and Gene Therapy Catapult.